ROR1 and B-cell chronic lymphocytic leukemia: Using immunoblot analyses we examined the levels of MMP-9 in CLL cells with low-to-negligible ROR1 (ROR1Neg) and in CLL cells with high levels of ROR1 (ROR1Pos), as defined in a prior study (Supplementary Table 1) [11].